ADEL-Y02

N/A

Report date: 2023/10/10 11:09:29

Base Information

Drug NameADEL-Y02

Drug Alias NameADEL-Y02

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionMicrotubule-associated protein tau inhibitors

TargetsMicrotubule-associated protein tau

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesADEL Inc

China Registration ClassN/A

Active CompaniesADEL Inc

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

ATC CodeN/A